Ir direto para menu de acessibilidade.

Sarampo mata. A vacina é a única maneira de prevenir a doença

    Você está aqui:
  1. Página inicial
  2. >
  3. CTIS2017
  4. >
  5. English
  6. >
  7. Presentations
Início do conteúdo da página

Presentations

Escrito por Tatiana Teles | Publicado: Quarta, 13 de Dezembro de 2017, 18h44 | Última atualização em Quarta, 13 de Dezembro de 2017, 18h44

November 29th , 2017

9h30 – 10h
Amazônia
Auditorium

Welcome
Camile Giaretta Sachetti
Director of the Department of Science and Technology, Secretariat of Science, Technology and Strategic Inputs, Brazilian Ministry of Health
Rodrigo Gomes Marques Silvestre
Director of the Department of Industrial Complex and Innovation in Health, Secretariat of Science, Technology and Strategic Inputs, Brazilian Ministry of Health

10h – 10h30
Amazônia
Auditorium

Connecting Research and Solutions – a success case
Ferid Murad
American pharmacologist awarded with the Nobel Prize in Medicine in 1998 for the discovery that nitric oxide (NO) acts as a signaling molecule in the cardiovascular system .

10h30 – 12h
Amazônia
Auditorium

PLENARY 1 
HEALTH 4.0: A REVOLUTION IN HEALTHCARE
Moderator: Roberto José da Silva Badaró (Universidade Federal da Bahia e SENAI-CIMATEC) - BRAZIL

10h – 10h30

Health 4.0 – How Virtualization and Big Data are Revolutionizing Healthcare
Christoph Thuemmler (Edinburgh Napier University) – UNITED KINGDOM

10h30 – 11h

Big Data in Health – Use of Big Data for research in Brazil: advances, obstacles and opportunities
Maurício Barreto (Centro de Integração de Dados e Conhecimentos para Saúde, Fiocruz) - BRAZIL

11h – 11h30

Internet of Things – Research and Innovation in Medical Devices in Brazil
Carlos Alberto P. Goulart (Aliança Brasileira da Indústria Inovadora em Saúde e Associação Brasileira da Indústria de Alta Tecnologia de Produtos para Saúde) - BRAZIL

13h – 14h30

 

ROUNDS OF CONVERSATION

ROOM ACÁCIA

The Cellular Technology Centers of the National Network of Cellular Therapy
Mari Sogayar (Rede Nacional de Terapia Celular)

ROOM BURITI

New biomarker for detection of hepatic steatosis based on clinical-laboratory characteristics of the multicenter ELSA-Brazil study
Hugo Perazzo (FIOCRUZ - RJ)
Molecular diagnosis and artificial intelligence as a solution to a public health problem: 40 thousand unnecessary thyroid surgeries per year in Brazil
Marcos Tadeu dos Santos (ONKOS Diagnósticos Moleculares LTDA)

ROOM MANDACARU

Pharmaceutical Market Regulation Chamber (CMED)
Bruno F. de Oliveira

14h30 – 17h

 

THEMATIC PANELS

Room Cerrado

Successful International Experiences in Clinical Research
Moderator: Alexandre Biasi (Hospital do Coração) - BRAZIL
The experience of the VIPER Institute in multicenter clinical trials
Leslie Victoria Boyer (University of Arizona) – UNITED STATES
Development of clinical studies at the NIH / USA: contributions to Brazil
Phillip Scheinberg (Hospital Beneficência Portuguesa de São Paulo) - BRAZIL
The French experience in clinical research: the Pôle Recherche Clinique
Claire Levy-Marchal (Institut National de la Santé et de la Recherche Médicale)  - FRANCE

Room Caatinga

New Therapeutic Approaches in Cellular and Molecular Immunology
Moderator: Leonilda Maria Barbosa dos Santos (Universidade Estadual de Campinas) - BRAZIL
Treg IL-2R as a target for the immunotherapy of autoimmunity
C. Garrison Fathman (Stanford Medical School e Department of Chemistry) – UNITED STATES
Role of regulatory T cells in health and disease
Robert Negrin (Stanford Medical School e Department of Chemistry) – UNITED STATES
Discovery of nitric oxide and cyclic GMP in cell signaling and their role in drug development
Ferid Murad (Stanford Medical School e Department of Chemistry) – UNITED STATES

Room Mata Atlântica

Challenges of Population Aging
Moderator: Yeda Duarte (Universidade de São Paulo) – BRAZIL
The longevity revolution
Ina Voelcker (Centro Internacional de Longevidade Brasil) - BRAZIL  
Economic Impact of Aging
Kaizo Iwakami Beltrão (Fundação Getúlio Vargas) - BRAZIL 
Aging and health
Márcia Carrera Campos Leal (Universidade Federal de Pernambuco) - BRAZIL

Room Pantanal

Arboviruses Scenario two years after the Zika Emergency 
Moderator: Pedro Vasconcellos (Instituto Evandro Chagas) - BRAZIL
Emerging Arboviruses: challenges to public health
Van-Mai Cao-Lormeau (Institut Louis Malardé) – FRENCH POLYNESIAN
Congenital abnormalities related to Zika and STORCH
Vanessa Van Der Linden (Universidade de Pernambuco) - BRAZIL
Economic impact of Chikungunya in Brazil
André Siqueira (Instituto Nacional de Infectologia, Fiocruz) - BRAZIL

 

November 30th , 2017

8h30 – 10h 
Araucária Auditorium

PLENARY 3
THE HUMAN BRAIN - PROSPECTS FOR FUTURE RESEARCH AND HEALTH INNOVATION
Moderator: Jorge Moll (Instituto D’OR) - BRAZIL

8h30 – 9h

Advances in Neurosciences of Instituto BRAINN – Brazilian Neuroscience and Neurotechnology
Fernando Cendes (Universidade Estadual de Campinas) - BRAZIL

9h – 9h30

Human Brain Project: Are we creating a Human Brain in a computer?
Richard Frackowiak (École Polytechnique Fédérale de Lausanne) – UNITED KINGDOM

9h30 – 10h

Debate

10h – 12h Auditório Araucária

PLENARY 4
Strategies and Challenges on Research, Development and Innovation

10h – 10h30

Innovation Strategies: The Experience of “Startup-Chile” Program
Yessenia Arlyn Carvajal Guerra (Programa Startup-Chile) - CHILE

10h30 – 12h

Discussing RD&I in Brazil: future strategies 
Moderador: Edimilson Ramos Migowski de Carvalho (President of Instituto Vital Brasil) - BRAZIL

13h – 14h30

 

ROUNDS OF CONVERSATION

ROOM ACÁCIA

Support and supply of stem cells in GMP conditions for use in clinical and therapeutic trials
Paulo Roberto Slud Brofman (CTC da PUC-PR)
 Advanced Therapy Products’s Regulation
João Batista da Silva Junior (ANVISA)

ROOM AROEIRA

REDPB - Use of mobile technology to collect data on people with disabilities
Silvana Santos (UEPB)

ROOM BURITI

The Innovation Hub of the IFBA and the EMBRAPII financing modeI
Handerson Jorge Dourado Leite (IFB/BA)
Clinical Research with Medicines: Regulatory Issues amidst Globalization
Flávia Sobral (ANVISA)

ROOM MANDACARU

Technologies to meet the limitations of cervical cancer screening in Brazil
Ramon Salinas (UNICAMP)
Current scenario and perspectives after Joint Ordinance 01/2017, INPI and  Anvisa
Liane Caldeira Lage (INPI)

14h30 – 17h

 

THEMATIC PANELS

Room Cerrado

From Research to the Development of Health Technologies: Innovations in Translational Research in The World and Brazilian Experiences
Moderator: Jorge Guimarães (Empresa Brasileira de Pesquisa e Inovação Industrial) - BRAZIL 
Translational Research Programs in the USA
Amy Dubois (United States Embassy) – UNITED STATES
Translational Research on Phytotherapy
João Batista Calixto (Centro de Inovação e Ensaios Pré-Clínicos) - BRAZIL
Development of Products in Health 100% national: the experience of UNESP/Botucatu on Translational Research 
Rui Seabra (Universidade Estadual Paulista) - BRAZIL
Translational Research on Photodynamic Therapy
Vanderlei Salvador Bagnato (Universidade de São Paulo) - BRAZIL

Room Caatinga

Resistance to Antimicrobials: What is the Future Scenario?
Moderator: Flávia Caselli Pacheco (Ministério da Saúde) - BRAZIL
The economic impact of antimicrobial resistance 
Jeremy Knox (Wellcome Trust) – UNITED KINGDOM
The impact of antimicrobial resistance in Brazil
Ana Cristina Gales (Universidade Federal de São Paulo) - BRASIL
Infections related to health care in Brazilian hospitals and the evaluation of antimicrobial use standards and policies
Antônio Carlos Campos Pignatari (Universidade Federal de São Paulo) - BRAZIL

Room Mata Atlântica

Genetic Editing and Advanced Cell Therapies and their Promising Health Applicability
Moderator: Mônica Ryff Moreira Roca Vianna (Pontifícia Universidade Católica do Rio Grande do Sul) - BRAZIL
Bioethical considerations of the use of genomic edition and cellular therapy
Søren Holm (Manchester University) – UNITED KINGDOM
Immunotherapy with NK cells
Lúcia Mariano da Rocha Silla (Hospital de Clínicas de Porto Alegre) - BRAZIL 
CART-CELL perspective for the treatment of hematological diseases
Martin Hernan Bonamino (Instituto Nacional do Câncer) - BRAZIL

Room Pantanal

Disruptive Technologies in Health - the Challenge of Connecting Progress and Accessibility
Moderator: Guilherme Rabello (InovaInCor) - BRAZIL
Disruptive Technologies in Diagnostic Medicine 
Roberto Ribeiro da Cruz (Pixeon) - BRAZIL
Artificial Intelligence and Health 
Eduardo Cipriani (IBM Watson Health) - BRAZIL

Room Pampa

Internationalization of Health Research Promotion
Moderator: Marcelo Morales (Conselho Nacional de Desenvolvimento Científico e Tecnológico) - BRAZIL
Transnational Translation of Knowledge in Research: Cancer Communications Perspective
Nelvis Castro (National Institutes of Health) – UNITED STATES
The Bill & Melinda Gates Foundation and fundraising to solving global health problems
Alexandre Menezes (Global Health Strategies, Bill & Melinda Gates Foundation) – BRAZIL
Collaborative Research and Innovation in Health: The Newton Fund Experience 
Rui Lopes (Fundo Newton) – BRAZIL

Auditorium Amazônia

From Science to Policy: Promoting Health Decision-Making
Moderator: Marcus Tolentino (Universidade Federal do Amazonas, Universidade Federal de Sorocaba) - BRAZIL
Evidence-Informed Policies: How to Move Forward in a Complex World?
Kaelan Moat (Mc Master University) - CANADA
Priorities of Scientific Evidences: production versus needs
Anne Andermann (McGill University) - CANADA 
Implementation Research to Improve Health Policies and Programs
Ludovic Reveiz (Organização Pan-Americana de Saúde) - BRAZIL 
Integration of Global and Local Evidence to Improve the Implementation of Health Policies
Jorge Otávio Maia Barreto (Fiocruz) - BRAZIL
Evidence-informed policies implementation: São Paulo experience 
Tereza Setsuko Toma (Secretaria de Saúde do Estado de São Paulo) - BRAZIL

registrado em:
Fim do conteúdo da página